Want to join the conversation?
Robert Jones of Goldman Sachs asks about restructuring program and $HSIC's plan on its extension. CFO Steven Paladino said that OpEx was down 35 basis points in 2Q16. He added that the company cannot give an estimate on the additional restructuring because it has not finalized that yet. However, $HSIC expects to cut down OpEx further, he said.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?